Giuseppe Boriani

Giuseppe Boriani's AcademicInfluence.com Rankings

Giuseppe Boriani

Medical

#1638

World Rank

#2000

Historical Rank

Cardiology

#130

World Rank

#133

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Giuseppe Boriani Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giuseppe Boriani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). (2020) (3378)
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (2221)
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. (2000) (964)
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (721)
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012) (637)
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. (2007) (607)
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (2014) (550)
213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (484)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. (2021) (467)
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration (2017) (417)
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. (2005) (378)
Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events (2009) (360)
Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) (2013) (350)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) (280)
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. (2001) (270)
Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia (2010) (257)
Cost-effectiveness of implantable cardioverter-defibrillators. (2001) (245)
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. (2012) (241)
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. (2021) (238)
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction (2006) (237)
Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. (2015) (235)
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. (2013) (229)
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS) (2019) (228)
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. (2016) (225)
Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial (2017) (224)
Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). (2014) (215)
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. (1992) (213)
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries endorsed by APHRS/HRS/LAHRS (2018) (203)
Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. (2005) (202)
Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. (2006) (190)
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. (1995) (184)
Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring (2011) (177)
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. (2001) (168)
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. (1994) (159)
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Elect (2017) (158)
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2018) (158)
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy: A Long-Term Longitudinal Study (2003) (157)
Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. (2015) (156)
Oral Propafenone To Convert Recent-Onset Atrial Fibrillation in Patients with and without Underlying Heart Disease (1997) (151)
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF (2016) (149)
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. (2014) (149)
Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE‐CARE multicentre randomized controlled trial (2017) (149)
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). (2015) (149)
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection wind (2009) (148)
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. (2014) (147)
Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block (2006) (145)
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. (2010) (145)
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (2022) (144)
Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). (2013) (142)
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. (2013) (140)
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. (2015) (137)
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. (2016) (137)
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. (2019) (134)
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisi (2015) (132)
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (2022) (128)
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. (1994) (127)
Phrenic Stimulation: A Challenge for Cardiac Resynchronization Therapy (2009) (124)
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (2018) (123)
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). (2017) (118)
Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. (2011) (116)
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes (2003) (115)
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (2018) (115)
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. (2004) (109)
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II (2010) (107)
Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. (1995) (106)
Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. (2010) (106)
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí (2017) (105)
Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial (2014) (103)
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation (2020) (103)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (103)
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I (2010) (102)
Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta‐analysis of randomized controlled trials in patients with heart failure (2016) (101)
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options (2011) (98)
Conversion of Recent‐Onset Atrial Fibrillation to Sinus Rhythm: Effects of Different Drug Protocols (1998) (98)
A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial. (2010) (95)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (2018) (94)
Worldwide Survey of COVID-19–Associated Arrhythmias (2021) (93)
Management of atrial high-rate episodes detected by cardiac implanted electronic devices (2017) (89)
The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. (2006) (85)
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study (2014) (85)
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring (2013) (84)
108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13–15 September 2002, Naarden, The Netherlands (2003) (83)
First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. (2012) (82)
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2016) (81)
Impact of Consistent Atrial Pacing Algorithm on Premature Atrial Complexe Number and Paroxysmal Atrial Fibrillation Recurrences in Brady-Tachy Syndrome: A Randomized Prospective Cross Over Study (2001) (81)
Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. (2009) (80)
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2017) (79)
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. (2013) (78)
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. (2019) (78)
‘Real-world’ atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (2016) (77)
Long-Term Complications Related to Biventricular Defibrillator Implantation: Rate of Surgical Revisions and Impact on Survival Insights From the Italian ClinicalService Database (2011) (76)
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. (2015) (75)
Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. (2017) (74)
Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation (2015) (72)
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction (2013) (72)
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care (2020) (72)
Effects of cardiac resynchronization therapy on left ventricular twist. (2008) (72)
Heart transplantation in hypertrophic cardiomyopathy. (2008) (71)
New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. (2014) (68)
Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. (1992) (67)
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. (1997) (67)
Electrophysiologic Manifestations of Ventricular Tachyarrhythmias Provoking Appropriate Defibrillator Interventions in High‐Risk Patients with Hypertrophic Cardiomyopathy (2007) (66)
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS) (2020) (66)
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. (2016) (66)
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Hear (2019) (65)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (65)
The EHRA White Book. (2012) (64)
A Prospective Randomized Evaluation of VV Delay Optimization in CRT‐D Recipients: Echocardiographic Observations from the RHYTHM II ICD Study (2009) (63)
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction (2010) (61)
Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation. (2016) (61)
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. (2002) (61)
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. (2009) (60)
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. (2008) (59)
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. (1997) (59)
Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era (2020) (58)
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation (2009) (58)
The wearable cardioverter-defibrillator: current technology and evolving indications (2017) (57)
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. (2020) (56)
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. (2008) (56)
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. (1999) (55)
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. (2005) (55)
Statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA). (2014) (55)
Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient? (2004) (54)
Meta‐analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all‐cause mortality and hospitalizations (2012) (54)
Cardiac Resynchronization Therapy: Variations in Echo‐Guided Optimized Atrioventricular and Interventricular Delays During Follow‐Up (2007) (54)
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. (2008) (54)
AF burden is important – fact or fiction? (2014) (53)
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) (2020) (53)
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding (2018) (53)
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardí (2017) (52)
Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. (2011) (52)
Role of ventricular Autocapture function in increasing longevity of DDDR pacemakers: a prospective study. (2006) (52)
Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives (2007) (52)
Benefits in Projected Pacemaker Longevity and in Pacing Related Costs Conferred by Automatic Threshold Tracking (2000) (51)
Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. (1998) (51)
Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment (2010) (51)
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response (2006) (51)
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. (2015) (50)
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. (2019) (49)
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio (2019) (49)
Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. (2009) (49)
Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation). (2015) (48)
Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use. (2019) (48)
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. (1996) (48)
Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real‐world’ data on long‐term outcomes (mortality, hospitalizations, days alive and out of hospital) (2016) (48)
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. (2013) (47)
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long‐term outcome (2007) (47)
[2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)]. (2022) (47)
Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID‐CRT risk score (2015) (47)
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination (1999) (47)
The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation (2018) (47)
Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. (2018) (45)
Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy (2011) (45)
Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width. (2008) (45)
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads (2018) (44)
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. (2015) (44)
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter–defibrillator systems (2011) (44)
Cardiac resynchronization by pacing: an electrical treatment of heart failure. (2004) (43)
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (2016) (42)
Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (2016) (42)
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. (2019) (42)
Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. (2000) (42)
Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association. (2019) (42)
Pharmacological cardioversion of atrial fibrillation: current management and treatment options. (2004) (41)
Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications. (2003) (41)
Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy. (2016) (41)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. (2021) (41)
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport. (2019) (41)
Evaluation by Cardiopulmonary Exercise Test of DDDR Versus DDD Pacing (1992) (41)
Actual Pacemaker Longevity: The Benefit of Stimulation by Automatic Capture Verification (2010) (40)
P-wave Variability and Atrial Fibrillation (2016) (40)
Predictors of long-term survival free from relapses after extraction of infected CIED (2018) (40)
Comparison of Two Strategies to Reduce Ventricular Pacing in Pacemaker Patients (2008) (40)
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study (2018) (40)
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (2021) (39)
Cardiac Resynchronization Therapy: State of the Art. (2015) (39)
Prediction of atrial fibrillation in patients with an implantable cardioverter‐defibrillator and heart failure (2010) (39)
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. (2001) (38)
Improving Thromboprophylaxis Using Atrial Fibrillation Diagnostic Capabilities in Implantable Cardioverter-Defibrillators: The Multicentre Italian ANGELS of AF Project (2012) (38)
Cost-effectiveness of cardiac resynchronisation therapy (2012) (38)
Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action (2020) (38)
Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods (2008) (37)
Cardiac Resynchronization Therapy With a Quadripolar Electrode Lead Decreases Complications at 6 Months: Results of the MORE-CRT Randomized Trial. (2016) (37)
Healthcare personnel resource burden related to in-clinic follow-up of cardiovascular implantable electronic devices: a European Heart Rhythm Association and Eucomed joint survey. (2011) (37)
Combined Use of Morphology Discrimination, Sudden Onset, and Stability as Discriminating Algorithms in Single Chamber Cardioverter Defibrillators (2002) (37)
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation (2017) (37)
Implant rates of cardiac implantable electrical devices in Europe: A systematic literature review. (2016) (36)
Paroxysmal atrial fibrillation in sleep. (1997) (36)
Propafenone in the Treatment of Cardiac Arrhythmias (1995) (36)
Cardioverter‐defibrillators after MADIT‐II: the balance between weight of evidence and treatment costs (2003) (35)
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants (2013) (35)
Pharmacological Cardioversion of Atrial Fibrillation (2012) (35)
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators (2018) (34)
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. (2019) (34)
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD). (2016) (34)
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) study: rationale and design. (2010) (34)
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. (2005) (33)
Outcome of cardioverter–defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy (2007) (33)
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. (1999) (33)
Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter‐defibrillator therapies and hospitalizations (2018) (33)
Impact of time to reperfusion after acute myocardial infarction on myocardial damage assessed by left ventricular longitudinal strain. (2009) (33)
Atrial Fibrillation Precipitating Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy (2002) (33)
Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications. (2008) (33)
Economic evaluation in cardiology. (2011) (33)
Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry). (2011) (32)
Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia? (2014) (32)
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters (2002) (32)
Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta‐analysis (2016) (32)
Electrocardiographic remodeling during cardiac resynchronization therapy. (2006) (31)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). (2022) (31)
Rhythm Discrimination by Rate Branch and QRS Morphology in Dual Chamber Implantable Cardioverter Defibrillators (2003) (31)
Persistent Atrial Fibrillation Worsens Heart Rate Variability, Activity and Heart Rate, as Shown by a Continuous Monitoring by Implantable Biventricular Pacemakers in Heart Failure Patients (2008) (31)
Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI) (2008) (31)
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. (2018) (31)
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. (2010) (31)
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study (2021) (30)
Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable? (2014) (30)
Impact of Cardiac Implantable Electronic Device Infection (2020) (30)
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. (2021) (29)
Rate control in atrial fibrillation: choice of treatment and assessment of efficacy. (2003) (29)
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation (2018) (29)
Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report (2018) (29)
Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration. (2020) (29)
Transvenous Low Energy Internal Cardioversion for Atrial Fibrillation: A Review of Clinical Applications and Future Developments (2001) (28)
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. (2016) (28)
Nightmares and Sleep Disturbances with Simvastatin and Metoprolol (2001) (28)
Transcatheter aortic valve implantation with a self‐expanding nitinol bioprosthesis (2012) (28)
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality. (2019) (28)
Atrial fibrillation prevention: an appraisal of current evidence (2017) (28)
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. (2008) (28)
Management of atrial fibrillation in bradyarrhythmias (2015) (27)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). (2017) (27)
Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent (2014) (27)
Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy (2016) (27)
Long‐Term RV Threshold Behavior by Automated Measurements: Safety is the Standpoint of Pacemaker Longevity! (2011) (27)
Prediction of Cardiac Resynchronization Therapy Response: Value of Calibrated Integrated Backscatter Imaging (2010) (27)
Clinical Evaluation of Morphology Discrimination: An Algorithm for Rhythm Discrimination in Cardioverter Defibrillators (2001) (27)
Atrial Tachyarrhythmia Recurrence Temporal Patterns in Bradycardia Patients Implanted with Antitachycardia Pacemakers (2004) (26)
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study. (2018) (26)
Sudden cardiac death in dialysis patients: different causes and management strategies. (2019) (26)
Low Energy Internal Atrial Cardioversion in Atrial Fibrillation Lasting More Than a Year (1999) (26)
Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection (2021) (26)
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis (2018) (25)
Phrenic stimulation management in CRT patients: are we there yet? (2011) (25)
Pacemaker-detected severe sleep apnea predicts new-onset atrial fibrillation (2017) (25)
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years (2020) (25)
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? (2011) (25)
Physical Activity Measured by Implanted Devices Predicts Atrial Arrhythmias and Patient Outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored) (2018) (24)
Expenditure and value for money: the challenge of implantable cardioverter defibrillators. (2009) (24)
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients (2013) (24)
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) (2018) (24)
Cardiac Resynchronization Therapy: (2005) (24)
Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children. (2006) (24)
Evolution of pacing for bradycardia: Autocapture (2007) (24)
A first described case of cancer-associated non-bacterial thrombotic endocarditis in the era of direct oral anticoagulants. (2017) (23)
Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator (2018) (23)
What do we do about atrial high rate episodes? (2020) (23)
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis (2021) (23)
Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences? (2017) (23)
Cardiac resynchronization therapy: a cost or an investment? (2011) (23)
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA (2018) (23)
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes (2018) (23)
Left Ventricular versus Biventricular Pacing: A Randomized Comparative Study Evaluating Mid‐Term Electromechanical and Clinical Effects (2007) (23)
The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not? (2016) (22)
Clinically oriented device programming in bradycardia patients: part 1 (sinus node disease). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) (2018) (22)
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. (2022) (22)
Mechanisms of pain associated with internal defibrillation shocks: results of a randomized study of shock waveform. (2005) (22)
Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry (2009) (22)
Atrial Threshold Variability: Implications for Automatic Atrial Stimulation Algorithms (2007) (22)
Remote monitoring and telemedicine in heart failure: implementation and benefits (2021) (22)
Automatic Management of Left Ventricular Stimulation: Hints for Technologic Improvement (2009) (22)
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization (2007) (22)
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients (2018) (22)
Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study (2018) (22)
Impact of COVID-19 Pandemic on Remote Monitoring of Cardiac Implantable Electronic Devices in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) (2021) (21)
Health economics and outcomes research: a new challenge and field of action for the European Heart Rhythm Association. (2010) (21)
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device (2021) (21)
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. (2006) (21)
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation. (2019) (21)
A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes. (1991) (21)
Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database (2016) (21)
Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial. (2019) (21)
The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. (2008) (21)
Implantation of cardioverter-defibrillator: effects on shoulder function. (2013) (20)
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation (2020) (20)
Short-spaced dipole for managing phrenic nerve stimulation in patients with CRT: the "phrenic nerve mapping and stimulation EP" catheter study. (2013) (20)
Cardiac Resynchronization and Implantable Cardioverter Defibrillator Therapy: Preliminary Results from the InSync Implantable Cardioverter Defibrillator Italian Registry (2003) (20)
Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology (2014) (20)
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. (2015) (20)
Globalization of the epidemiologic, clinical, and financial burden of atrial fibrillation. (2012) (20)
Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology. (2011) (20)
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). (2018) (20)
Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome. (2010) (20)
Oral Loading with Propafenone: A Placebo‐Controlled Study in Elderly and Nonelderly Patients with Recent Onset Atrial Fibrillation (1998) (20)
Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure (2007) (20)
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death (2007) (19)
Effect of Cardiac Resynchronization Therapy on Left Atrial Size and Function as Expressed by Speckle Tracking 2-Dimensional Strain. (2016) (19)
Detect Long‐term Complications After ICD Replacement (DECODE): Rationale and Study Design of a Multicenter Italian Registry (2015) (19)
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration (2022) (19)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial (2020) (19)
High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D, L-sotalol. (2000) (19)
Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management. (2020) (19)
Cardiac resynchronization therapy and cardiac sympathetic function (2015) (19)
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. (2021) (19)
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1‐year outcomes in the EORP‐AF General Pilot Registry (2018) (19)
The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker. (2008) (19)
Impact of Mitral Regurgitation on the Outcome of Patients Treated with CRT‐D: Data from the InSync ICD Italian Registry (2012) (19)
Is cardiac resynchronization therapy cost-effective? (2009) (19)
Predictors of Atrial Antitachycardia Pacing Efficacy in Patients Affected by Brady‐Tachy Form of Sick Sinus Syndrome and Implanted with a DDDRP Device (2005) (19)
Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 Dual Defibrillator Italian Registry (2001) (19)
Intrahospital organizational model of remote monitoring data sharing, for a global management of patients with cardiac implantable electronic devices: a document of the Italian Association of Arrhythmology and Cardiac Pacing. (2020) (18)
Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke. (2011) (18)
Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey. (2017) (18)
Effects of cardiac resynchronization therapy on coronary blood flow: Evaluation by transthoracic Doppler echocardiography ☆ (2008) (18)
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry. (2020) (18)
Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice (2020) (18)
Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function (2018) (18)
Effect of Left Ventricular Function on Long-Term Left Ventricular Pacing and Sensing Threshold (2002) (18)
Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project). (2014) (18)
Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry (2001) (18)
Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years? (2018) (18)
Implantable cardioverter defibrillators: from evidence of trials to clinical practice (2007) (18)
Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes (2019) (17)
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). (2019) (17)
Effects of consistent atrial pacing and atrial rate stabilization - two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome (2001) (17)
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies (2011) (17)
Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD. (2015) (17)
Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure. (2020) (17)
Left ventricular pacing by automatic capture verification. (2007) (17)
Biventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study. (2006) (17)
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. (2021) (17)
Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients (2021) (17)
New left ventricular active fixation lead: The experience of lead extraction (2015) (17)
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry. (2016) (17)
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction". (2009) (17)
Seventeen-year trend (2001-2017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: An analysis by age groups. (2020) (16)
The cost of atrial fibrillation in Italy: a five-year analysis of healthcare expenditure in the general population. From the Italian Survey of Atrial Fibrillation Management (ISAF) study. (2017) (16)
The OPTI-MIND study: a prospective, observational study of pacemaker patients according to pacing modality and primary indications. (2014) (16)
The epidemiologic threat of atrial fibrillation: need for secondary, primary, and primordial prevention. (2015) (16)
Clinically oriented device programming in bradycardia patients: part 2 (atrioventricular blocks and neurally mediated syncope). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) (2018) (16)
Holter ECG for pacemaker/defibrillator carriers: what is its role in the era of remote monitoring? (2015) (16)
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? (2011) (16)
Far‐Field R Wave Oversensing in Dual Chamber Pacemakers Designed for Atrial Arrhythmia Management: (2004) (16)
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? (2019) (16)
Atrial Evoked Response Integral for Automatic Capture Verification in Atrial Pacing (2003) (16)
Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms. (1998) (15)
Oral Loading with Propafenone for Conversion of Recent-Onset Atrial Fibrillation (2012) (15)
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD). (2016) (15)
Five year trends (2008–2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases (2018) (15)
Cost-effectiveness of implantable cardioverter-defibrillator in today's world. (2014) (15)
Usefulness of nicorandil in congestive heart failure. (1990) (15)
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device. (2006) (15)
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry (2021) (15)
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients. (2006) (15)
Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial (2020) (15)
Non-valvular atrial fibrillation: potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants (2015) (15)
Effect of high-pass filtering on ECG signal on the analysis of patients prone to atrial fibrillation. (2009) (15)
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study. (2017) (15)
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. (2008) (15)
Evaluation of a Dual Chamber Implantable Cardioverter Defibrillator for the Treatment of Atrial and Ventricular Arrhythmias (2003) (15)
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. (2012) (15)
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation. (2004) (14)
Automatic Verification of Ventricular Stimulation: Fusion Management Algorithm (2007) (14)
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. (2021) (14)
Role of drugs and devices in patients at risk of sudden cardiac death (2010) (14)
Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study. (2019) (14)
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey (2021) (14)
Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients (2022) (14)
Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy (2005) (14)
Current clinical perspectives on implantable devices for atrial defibrillation (2002) (14)
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes (2018) (14)
Flecainide: evidence of non-linear kinetics (2004) (13)
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease (2020) (13)
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies (2017) (13)
Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach. (2013) (13)
Clinically guided pacemaker choice and setting: pacemaker expert programming study (2016) (13)
Arrhythmias Originating in the Atria. (2017) (13)
Quantification of Fatty Tissue Mass by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia (2005) (13)
Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks. (1999) (13)
Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blin (2016) (13)
Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects. (1993) (13)
Drugs, gery, Cardioverter Defibrillator: A Decision Based on the Clinical Problem (1993) (13)
Predictors of Atrial Defibrillation Threshold in Internal Cardioversion (2000) (13)
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation. (2019) (13)
Transvenous Cardioverter‐Defibrillator Implantation in a Patient with Tricuspid Mechanical Prosthesis (2007) (13)
Outcomes with Dronedarone in Atrial Fibrillation: What Differences Between Real-World Practice and Trials? A Meta-Analysis and Meta-Regression Analysis. (2017) (13)
Favorable Trend of Implantable Cardioverter‐Defibrillator Service Life in a Large Single‐Nation Population: Insights From 10‐Year Analysis of the Italian Implantable Cardioverter‐Defibrillator Registry (2019) (12)
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise. (2016) (12)
Rate Control in Atrial Fibrillation (2012) (12)
Neuro-arrhythmology: a challenging field of action and research: a review from the Task Force of Neuro-arrhythmology of Italian Association of Arrhythmias and Cardiac Pacing. (2019) (12)
Primary Prevention of Sudden Cardiac Death: Can We Afford the Cost of Cardioverter‐Defibrillators? Data from the Search‐MI Registry‐Italian Sub‐study (2006) (12)
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (2017) (12)
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. (2022) (12)
Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress (2017) (12)
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices (2015) (12)
Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmias (2019) (12)
Atrial Fibrillation Therapy in Patients with a CRT Defibrillator with Wireless Telemetry (2009) (12)
Cardiac Resynchronization Therapy: An Overview on Guidelines. (2017) (12)
Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant. (2002) (12)
OLBI pacing - The Italian experience (1997) (12)
Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England. (2021) (12)
Temporal Variability of Atrial Fibrillation in Pacemaker Recipients for Bradycardia: Implications for Crossover Designed Trials, Study Sample Size, and Identification of Responder Patients by Means of Arrhythmia Burden (2007) (12)
Comparison of cryoballoon and radiofrequency ablation techniques for atrial fibrillation: a meta-analysis (2018) (12)
Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients. (2013) (12)
Atrial fibrillation in patients with cardiac implantable electronic devices: new perspectives with important clinical implications. (2019) (12)
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort (2021) (12)
Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation (2018) (11)
Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response. (1998) (11)
Duration of P‐Wave Is Associated with Atrial Fibrillation Hospitalizations in Patients with Atrial Fibrillation and Paced for Bradycardia (2007) (11)
Meta-analysis of Clinical Outcomes of Electrical Cardioversion and Catheter Ablation in Patients with Atrial Fibrillation and Chronic Kidney Disease. (2018) (11)
Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. (2010) (11)
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling. (2011) (11)
Cohort profile The ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. (2020) (11)
[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017]. (2019) (11)
Home care for heart failure: can caregiver education prevent hospital admissions? A randomized trial in primary care (2019) (11)
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset (2019) (11)
Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis? (2015) (11)
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. (2021) (11)
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry (2021) (11)
Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. (2005) (11)
Role of cardiovascular imaging in cardiac resynchronization therapy: a literature review (2018) (11)
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) (2019) (10)
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference (2022) (10)
Interventricular Delay Optimization: A Comparison among Three Different Echocardiographic Methods (2010) (10)
Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. (2015) (10)
The struggle against infections of cardiac implantable electrical devices: the burden of costs requires new personalized solutions. (2018) (10)
Screening for atrial fibrillation: Need for an integrated, structured approach. (2019) (10)
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study. (2020) (10)
Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. (2016) (10)
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead (2013) (10)
Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group. (2019) (10)
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation. (2018) (10)
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? (2010) (10)
Managing atrial fibrillation: the need for an individualized approach even in the emergency department (2019) (10)
Cardiac Electronic Devices: Future Directions and Challenges (2020) (10)
Stroke/thromboembolism and intracranial hemorrhage in a real-world atrial fibrillation population: the Complications of Atrial Fibrillation in the Bologna Area (CAFBO) study. (2014) (10)
Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators (2014) (10)
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs (2015) (10)
Efficacy of cardiac resynchronization therapy in patients with isolated ventricular noncompaction with dilated cardiomyopathy: a systematic review of the literature (2018) (10)
Long‐Term Follow‐Up of Patients with Syncope Evaluated by Head‐Up Tilt Test (2010) (10)
Is ventricular sensing always right, when it is left? (2018) (10)
On the resolution of ECG acquisition systems for the reliable analysis of the P-wave (2012) (10)
A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation (2016) (10)
Cardiac resynchronization therapy in the real world: need to focus on implant rates, patient selection, co-morbidities, type of devices, and complications (2017) (9)
The ventricular ectopic QRS interval (VEQSI): Diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression. (2016) (9)
[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography]. (1989) (9)
Clinical and organizational management of cardiac implantable electronic device replacements: an Italian Survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). (2019) (9)
Remote Monitoring of Patients with an Implanted Device and Patients’ Outcomes: The Potential for “Win‐Win” Dynamics (2009) (9)
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology (2021) (9)
Heterogeneous response of cardiac sympathetic function to cardiac resynchronization therapy in heart failure documented by 11[C]-hydroxy-ephedrine and PET/CT. (2015) (9)
Implantable Dual-Chamber Defibrillator for the Selective Treatment of Spontaneous Atrial and Ventricular Arrhythmias: Arrhythmia Incidence and Device Performance (2005) (9)
Health economics and the European Heart Rhythm Association. (2011) (9)
Painless Shock Therapy: More Than Just an Attempt to Square the Circle? (2007) (9)
Paroxysmal atrial fibrillation in sleep (1993) (9)
High sensitivity C-reactive protein (hsCRP) and its implications in cardiovascular outcomes. (2020) (9)
Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels (2019) (9)
Amyloid deposition as a cause of atrial remodeling in persistent valvular atrial fibrillation (2004) (9)
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation (2006) (9)
Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial. (2017) (9)
How, Why, and When May Atrial Defibrillation Find a Specific Role in Implantable Devices? A Clinical Viewpoint (2007) (9)
Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. (2017) (9)
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation. (2021) (9)
Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope (2021) (9)
Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co‐morbidities (2017) (9)
Atrial Fibrillation and Aging: Risky Mutual Relationships. (2016) (9)
Transvenous internal cardioversion for atrial fibrillation: a randomized comparison between catheters with different coil length. (2002) (9)
Long-term progression of rhythm and conduction disturbances in pacemaker recipients: findings from the Pacemaker Expert Programming study (2018) (9)
COVID-19 pandemic: usefulness of telemedicine in management of arrhythmias in elderly people (2020) (9)
Reduction of unnecessary right ventricular pacing due to the managed ventricular pacing (MVP) mode in patients with symptomatic bradycardia: Benefit for both sinus node disease and AV block indications (2005) (9)
Short-term onset of fatal pulmonary toxicity in a patient treated with intravenous amiodarone for post-operative atrial fibrillation. (2012) (9)
Cardiac resynchronization therapy in the real world: need to upgrade outcome research (2018) (8)
β-Blocking Properties of Propafenone in Extensive Oxidisers: A Study on Heart Rate Behaviour during Holter Monitoring (1993) (8)
Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes (2021) (8)
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). (2019) (8)
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes (2021) (8)
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. (2005) (8)
Extending survival by reducing sudden death with implantable cardioverter‐defibrillators: a challenging clinical issue in non‐ischaemic and ischaemic cardiomyopathies (2018) (8)
Mobile health technology in atrial fibrillation (2022) (8)
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project (2017) (8)
Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide (2017) (8)
How did COVID-19 affect medical and cardiology journals? A pandemic in literature (2021) (8)
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients (2020) (8)
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling (2021) (8)
Evaluation of Atrial Refractoriness and Atrial Fibrillation Inducibility Immediately after Internal Cardioversion in Patients with Chronic Persistent Atrial Fibrillation (1999) (8)
Uneventful right ventricular perforation with displacement of a pacing lead into the left thorax. (2008) (8)
Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples (2017) (8)
Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III (2022) (8)
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'. (2022) (8)
Atrial Signal Analysis and Defibrillation Threshold Assessment in Chronic Persistent and Reinduced Atrial Fibrillation (2002) (8)
Left Ventricular Reverse Remodeling Elicited by a Quadripolar Lead: Results from the Multicenter Per4mer Study (2016) (8)
[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. (1996) (8)
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. (2005) (8)
Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs (2019) (8)
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients (2019) (8)
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? (2016) (8)
[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2016]. (2018) (8)
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation. (2019) (8)
Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry. (2022) (8)
Plateau Waveform Shape Allows a Much Higher Patient Shock Energy Tolerance in AF Patients (2007) (7)
Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome (2022) (7)
Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation. (2017) (7)
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (2022) (7)
Kidney dysfunction and short term all-cause mortality after transcatheter aortic valve implantation. (2020) (7)
Neurocardiogenic Syncope in Selected Pediatric Patients—Natural History during Long-Term Follow-Up and Effect of Prophylactic Pharmacological Therapy (2001) (7)
Effects of cardiac resynchronization therapy on myocardial contractile reserve during exercise (2011) (7)
Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy (2016) (7)
Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome. (2007) (7)
Different pharmacologic treatment for converting recent-onset atrial fibrillation: Evaluation on 377 patients (1996) (7)
Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction. (2004) (7)
Temporary transvenous cardiac pacing: a survey on current practice. (2020) (7)
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2016) (7)
Effects of Cardiac Resynchronization Therapy on Diastolic Function: Evaluation by Radionuclide Angiography (2007) (7)
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden (2013) (7)
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation (2018) (7)
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis (2020) (7)
Searching for Atrial Fibrillation Poststroke (2019) (7)
The empowerment of translational research: lessons from laminopathies (2012) (7)
Cardiac resynchronization therapy: the conundrum of predicting response in the individual patient. (2014) (7)
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications (2011) (7)
Abstract 13509: Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation: The Certify Study (2013) (7)
Clinical reliability of single-lead VDD pacing from evaluation of P-wave sensing under dynamic conditions. (1998) (7)
Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators. (2008) (7)
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. (2016) (7)
Atrial fibrillation: adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. (2010) (7)
Five waves of COVID-19 pandemic in Italy: results of a national survey evaluating the impact on activities related to arrhythmias, pacing, and electrophysiology promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) (2022) (7)
Impact of COVID-19 in emergency medicine literature: a bibliometric analysis (2022) (7)
Excimer laser lead extraction by femoral approach. (2011) (7)
Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program. (2020) (7)
Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. (2015) (6)
Optimal Use of Echocardiography in Management of Thrombosis After Anterior Myocardial Infarction (2020) (6)
Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia. (2008) (6)
Tailored treatment strategies: a new approach for modern management of atrial fibrillation (2016) (6)
Optimization of Pacing Algorithms to Prevent and Treat Supraventricular Tachyarrhythmias (2006) (6)
Incompatibility between intravenous amiodarone and heparin in an infant. (2010) (6)
Evaluation of the Atrial Evoked Response for Capture Detection with High‐Polarization Leads (2005) (6)
Abnormal Cardiac Innervation in Patients with Idiopathic Ventricular Fibrillation (2003) (6)
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia (2022) (6)
Red Cell Distribution Width and Patient Outcome in Cardiovascular Disease: A ‘’Real-World’’ Analysis (2021) (6)
Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey (2021) (6)
One-year clinical events and management of patients with atrial fibrillation hospitalized in cardiology centers: Data from the BLITZ-AF study. (2020) (6)
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus. (2011) (6)
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry (2022) (6)
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data (2013) (6)
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe (2022) (6)
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. (2021) (6)
Comparison of Induced and Spontaneous Atrial Tachyarrhythmias in Patients with a History of Spontaneous Atrial Tachyarrhythmias (2005) (6)
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? (2022) (6)
Tocainide and metoprolol: An efficacious therapeutic combination in the treatment of premature ventricular beats (1989) (6)
Fluttering waves in electrocardiograms recorded in neonatal intensive care unit. (2003) (6)
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. (2011) (6)
[2017 Catheter Ablation Registry of the Italian Association of Arrhythmology and Cardiac Pacing]. (2019) (6)
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal (2018) (6)
Remodeling classification system considering left ventricular volume in patients with aortic valve stenosis: Association with adverse cardiovascular outcomes (2019) (6)
Intravenous administration of propafenone. (1992) (6)
Massive pulmonary embolism with acute coronary syndrome-like electrocardiogram mimicking acute left main coronary artery obstruction. (2012) (6)
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial (2011) (6)
[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2018]. (2020) (6)
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants. (2020) (6)
Clinical experience with downsized lower energy output implantable cardioverter defibrillators. Ventak Mini II Clinical Investigators. (1998) (6)
Increase in QT/QTc dispersion after low energy cardioversion of chronic persistent atrial fibrillation. (2004) (6)
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care. (2018) (6)
Late Improvement in Ventricular Performance Following Internal Cardioversion for Persistent Atrial Fibrillation: (2003) (6)
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications. (2014) (5)
Effects of Anti-vitamin k oral anticoagulants on bone and cardiovascular health. (2020) (5)
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation (2022) (5)
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation. (2020) (5)
Shoulder function after cardioverter defibrillator implantation: five year follow up. (2019) (5)
[Cerebral and renal aspergillosis in a patient with orthotopic heart transplant: diagnosis, treatment and follow-up]. (1989) (5)
Sunday, 26 August 2012 (2012) (5)
Changes in global longitudinal strain during rest and exercise in patients treated with cardiac resynchronization therapy (2012) (5)
Resolution of atrial thrombosis with heparin in a newborn with atrial flutter (2009) (5)
The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring (2021) (5)
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors (2021) (5)
Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration (2022) (5)
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization (2016) (5)
Cardioverter defibrillators in primary prevention of sudden cardiac death: a cost or an investment? (2007) (5)
Heart failure after myocardial revascularization: risk markers. (2005) (5)
The 12-lead ECG: a continuous reference for the cardiologist. (2019) (5)
Infective endocarditis in patients with cardiac implantable electronic devices: Impact of comorbidities on outcome. (2019) (5)
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study (2012) (5)
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden (2017) (5)
QRS interval time-related changes and prognosis in heart failure. (2003) (5)
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. (2010) (5)
Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality. (2016) (5)
Complicated myocardial infarction in a 99-year-old lady in the era of COVID-19 pandemic: from the need to rule out coronavirus infection to emergency percutaneous coronary angioplasty (2020) (5)
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations (2020) (4)
Ventricular dyssynchrony at echo: Detection by two-dimensional tracking and tissue doppler imaging in candidates to biventricular pacing (2008) (4)
Impact of pacemaker longevity on expected device replacement rates: Results from computer simulations based on a multicenter registry (ESSENTIAL) (2018) (4)
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications. (2022) (4)
Cost‐minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications (2021) (4)
Relevance of Monitoring Atrial Fibrillation in Clinical Practice. (2012) (4)
Cardiac Resynchronization Therapy: An Overview on Guidelines. (2015) (4)
Female sex and stroke in atrial fibrillation: an intriguing relationship (2019) (4)
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients (2021) (4)
Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction (2020) (4)
Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. “Routine Practice” data from the SEARCH MI registry (2012) (4)
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
Occurrence of atrial fibrillation in pacemaker patients and its association with sleep apnea and heart rate variability. (2019) (4)
Screening for Atrial Fibrillation in Relation to Stroke and Mortality Risk (2021) (4)
Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus. (2021) (4)
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2018) (4)
964-8 Oral Loading with Propafenone in Recent-Onset Atrial Fibrillation: A Controlled Evaluation on 240 Patients (1995) (4)
Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)". (2005) (4)
Left ventricular pacing rate lower than expected during manual pacing threshold test in a biventricular defibrillator. (2013) (4)
AB7-2: Plateau waveform shape allows a higher patient shock energy tolerance (2006) (4)
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. (2021) (4)
Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry (2022) (4)
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. (2021) (4)
A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardia (2002) (4)
New classification of geometric patterns considering left ventricular volume in patients with chronic aortic valve regurgitation: Prevalence and association with adverse cardiovascular outcomes (2018) (4)
Evaluation of Fusion Beat Detection with a New Ventricular Automatic Capture Algorithm in ICDs (2005) (4)
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. (2022) (4)
Clinical Value of Complex Echocardiographic Left Ventricular Hypertrophy Classification Based on Concentricity, Mass, and Volume Quantification (2021) (4)
Letter by Gasparini and Boriani regarding article, "Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)". (2013) (4)
Radar-Based Monitoring of Vital Signs: A Tutorial Overview (2023) (3)
DDD and single‐lead VDD pacing: Evaluation of atrial signal dynamic changes (2000) (3)
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke (2022) (3)
Local amyloidosis as a possible component of the atrial remodeling accompanying atrial fibrillation [corrected]. (2008) (3)
[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2015]. (2017) (3)
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores (2019) (3)
Atrial fibrillation: favorable effects of flecalnide in transvenous low energy internal atrial cardioversion (1998) (3)
Atrial Fibrillation in Patients with a Dual Defibrillator: Characteristics of Spontaneous and Induced Episodes and Effect of Ventricular Tachyarrhythmia Induction (2005) (3)
Effect of ECG filtering on time domain analysis of the P-wave (2008) (3)
How to RESPOND to the quest to increase the effectiveness of cardiac resynchronization therapy? (2016) (3)
Cardiac resynchronization therapy in atrial fibrillation patients: amultinational registry: the certify study (2013) (3)
Clinical and therapeutic implications of troponin elevation in cardiac arrest. (2004) (3)
Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry (2020) (3)
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation (2021) (3)
Optimized Implementation of cardiac resynchronization therapy – a call for action for referral and optimization of care (2021) (3)
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry. (2022) (3)
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario. (2020) (3)
A closer look into the complexity of our practice: Outcome research for transvenous temporary cardiac pacing. (2018) (3)
Lead choice in cardiac implantable electronic devices: an Italian survey promoted by AIAC (Italian Association of Arrhythmias and Cardiac Pacing) (2019) (3)
Prolonged QRS and QTc interval and mortality. (2008) (3)
Atrial Remodeling: Evolving Concepts (2003) (3)
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil (2021) (3)
Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association (2019) (3)
Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry (2021) (3)
European Society of Cardiology-Proposed Diagnostic Echocardiographic Algorithm in Elective Patients with Clinical Suspicion of Infective Endocarditis: Diagnostic Yield and Prognostic Implications in Clinical Practice (2018) (3)
Continuous monitoring of sleep‐disordered breathing with pacemakers: Indexes for risk stratification of atrial fibrillation and risk of stroke (2020) (3)
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes (2021) (3)
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. (2021) (3)
Beat-to-beat variability of P-wave in patients suffering from atrial fibrillation (2016) (3)
Prevalence and clinical significance of left bundle branch block according to classical or strict definition criteria in permanent pacemaker patients (2017) (3)
Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation (2017) (3)
Reshaping of Italian Echocardiographic Laboratories Activities during the Second Wave of COVID-19 Pandemic and Expectations for the Post-Pandemic Era (2021) (3)
Monday, 27 August 2012 (2012) (3)
The effects of gender on electrical therapies for the heart: procedural considerations, results and complications A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC) (2017) (3)
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal (2018) (3)
Biomarkers in atrial fibrillation: a constant search for simplicity, practicality, and cost-effectiveness. (2021) (3)
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis (2022) (3)
AIM‐AF: A Physician Survey in the United States and Europe (2022) (3)
Cardiomyopathy associated with long‐term right ventricular pacing: an intriguing clinical issue (2019) (3)
Decrease in Patient Radiation Exposure by a Tantalum Filter during Electrophysiological Procedures (2009) (3)
Repolarization Changes in a Double‐Blind Crossover Study of Dofetilide Versus Sotalol in the Treatment of Ventricular Tachycardia (2000) (3)
Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry. (2022) (3)
Beat-to-beat analysis of P waves in patient with atrial fibrillation history (2016) (3)
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature (2022) (3)
Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy (2016) (3)
Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey. (2022) (3)
Burden of disease and costs of infections associated with cardiac implantable electronic devices (2021) (3)
Prophylactic cardioverter defibrillator utilization in the "real world": a conundrum. (2012) (3)
Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation (2022) (2)
Role of severe functional mitral regurgitation in predicting electrical remodeling in idiopathic dilated cardiomyopathy (2006) (2)
Impact of prevention pacing algorithms on atrial tachyarrhythmia recurrence patterns in patients suffering from brady-tachy form of sick sinus syndrome: A randomized study (2003) (2)
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients (2021) (2)
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply. (2022) (2)
Solution to a crushing dosage problem? (2004) (2)
Effect on mortality of different routes of administration and loading dose of aspirin in patients with ST-segment elevation acute myocardial infarction treated with primary angioplasty (2020) (2)
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective. (2022) (2)
Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol. (2017) (2)
Internal Low Energy Atrial Cardioversion: Efficacy and Safety in Older Patients with Chronic Persistent Atrial Fibrillation (2001) (2)
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? (2022) (2)
The QRS interval in patients treated with resynchronization therapy: which value? (2009) (2)
Cardiac resynchronization therapy: need to synchronize patients and device longevities with comorbidities. (2018) (2)
Prevention of Sudden Death in Hypertrophic Cardiomyopathy (2004) (2)
Peri‐operative management of patients taking antithrombotic therapy: need for an integrated proactive approach (2011) (2)
P994Is post-shock pacing really needed in ICD patients? Preliminary results from the IMPLANTED registry (2017) (2)
Association between implantable defibrillator‐detected sleep apnea and atrial fibrillation: The DASAP‐HF study (2022) (2)
Feasible approaches and implementation challenges to atrial fibrillation screening: a qualitative study of stakeholder views in 11 European countries (2022) (2)
Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry. (2022) (2)
Antiarrhythmic effect of reverse ventricular remodelling induced by cardiac resynchronization therapy [Artigo recomendado do mês] (2008) (2)
Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis. (2016) (2)
Pacing prevention of atrial tachyarrhythmias: preliminary results from the Italian AT500 registry (2002) (2)
Measuring P-wave Morphological Variability for AF-prone Patients Identification (2011) (2)
Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection (2021) (2)
Prognostic value of implantable defibrillator-computed respiratory disturbance index: The DASAP-HF study. (2020) (2)
Temporal patterns of premature atrial complexes predict atrial fibrillation occurrence in bradycardia patients continuously monitored through pacemaker diagnostics (2019) (2)
Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry (2022) (2)
Performance and clinical comparison between left ventricular quadripolar and bipolar leads in cardiac resynchronization therapy: Observational research (2018) (2)
Screening for Atrial Fibrillation in Relation to Stroke and Mortality Risk (2021) (2)
How do cardiologists face health economics and health technology assessments? (2012) (2)
12-year Temporal Trend in Referral Pattern and Test Results of Stress Echocardiography in a Tertiary Care Referral Center with Moderate Volume Activities and Cath-lab Facility (2018) (2)
Rate control in AFFIRM: considerations about the clinical implications. (2004) (2)
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections (2021) (2)
P-wave characteristics after electrical external cardioversion: Predictive indexes of relapse (2010) (2)
DDDR versus DDD and VVIR pacing: A single blind randomised evaluation of symptoms and effort performance (1993) (2)
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach. (2020) (2)
Beta-blocker treatment guided by head-up tilt test in neurally mediated syncope (1997) (2)
Cardiac resynchronization therapy: is systole all that matters? (2010) (2)
Clinical management of electrical storm: a current overview (2020) (2)
Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry (2022) (2)
Case of the month by the EHRA Education committee: exercise-related arrhythmias. (2008) (2)
REDUCTION IN UNNECESSARY VENTRICULAR PACING FAILS TO AFFECT HARD CLINICAL OUTCOMES: A META-ANALYSIS (2015) (2)
Organization and procedures in contemporary catheter ablation centres: data from the 2018 Italian Catheter Ablation Registry (2021) (2)
Abstract 4856: Could a Simplified Biventricular Icd Device be Safe and Effective in Patients with Non-Ischemic Heart Failure? Results from the Relevant Study (2008) (2)
SMARTPHONE-BASED CIED REMOTE MONITORING: IMPROVED COMPLIANCE AND CONNECTIVITY (2022) (2)
Nationwide survey on the current practice of ventricular tachycardia ablation. (2019) (2)
Winning the war, far, in developing countries. Novel anticoagulants as a new weapon against stroke. (2012) (2)
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices. (2020) (2)
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation (2)
1315Effectiveness of a reactive atrial antitachycardia pacing feature in patients with ICDs: A large database analysis (2017) (2)
[The BLOCK HF study]. (2013) (2)
Imaging functional stress test for stable chest pain symptoms in patients at low pretest probability of coronary artery disease: Current practice and long‐term outcome (2019) (2)
The "rope and stick" and the "safety snare": two new techniques for tricky lead extractions. (2012) (2)
[2019 Catheter Ablation Registry of the Italian Association of Arrhythmology and Cardiac Pacing]. (2021) (1)
Propafenone as single oral loading dose versus placebo in recent-onset atrial fibrillation: Effects in patients with and without structural heart disease (1996) (1)
Prevention of long‐lasting atrial fibrillation through antitachycardia pacing in DDDR pacemakers (2020) (1)
The Challenge of Preventing Stroke in Elderly Patients With Atrial Fibrillation (2011) (1)
Reply to reader's comment: "Electrocardiographic optimization of cardiac resynchronization devices: simple, but not so simple!" by Mont et al. (2009) (1)
Degree of left ventricular dilatation at end‐diastole: Correlation and prognostic utility of quantitative volumes by 2D‐echocardiography versus linear dimensions in patients with asymptomatic aortic regurgitation (2020) (1)
P-376 A new algorithm for ventricular automatic capture detection in ICDS (2003) (1)
Predicting all-cause mortality by means of multisensor implantable defibrillator algorithm for HF monitoring. (2023) (1)
Low Levels of Vitamin D and Silent Myocardial Ischemia in Type 2 Diabetes: Clinical Correlations and Prognostic Significance (2022) (1)
Fusion beat detection in ICDs with a new ventricular automatic capture detection algorithm (2004) (1)
Atrial tachyarrhythmia recurrence: Temporal patterns (2003) (1)
Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy: Clinical Management and Outcome. (2013) (1)
The Practice of Deep Sedation in Electrophysiology and Cardiac Pacing Laboratories: Results of an Italian Survey Promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing) (2021) (1)
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". (2008) (1)
Association Between Device-Detected Sleep-Disordered Breathing and Implantable Defibrillator Therapy in Patients With Heart Failure. (2022) (1)
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry (2022) (1)
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? (2022) (1)
Outcomes of digoxin vs. beta-blocker in AF: report from ESC-EHRA EORP-AF Long-Term General Registry. (2021) (1)
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction (2022) (1)
Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial. (2018) (1)
Arrhythmias in COVID-19/SARS-CoV-2 Pneumonia Infection: Prevalence and Implication for Outcomes (2022) (1)
Arrhythmogenic right ventricular cardiomyopathy as cause of severe heart failure leading to heart transplantation (2013) (1)
Internal atrial cardioversion in atrial fibrillation. (2000) (1)
[Determination of oxidative phenotype in a sample population and correlation with the pharmacokinetics of propafenone]. (1990) (1)
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation (2021) (1)
P840Understanding the incidence of AF in single chamber ICD patients: a real world analysis (2017) (1)
Young subjects with apparently idiopathic complex ventricular arrhythmias: Non-invasive cardiological evaluation and follow-up (1993) (1)
[Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone]. (1991) (1)
Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (1)
Abstract 2691: Prophylactic Implantable Defibrillator in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Sustained Ventricular Tachyarrhythmias: Therapy-Based Risk Stratification During a Long Term Follow-up (2006) (1)
Implantable Cardioverter Defibrillators for Ventricular Tachyarrhythmia: Current Status and Technological Evolution (2001) (1)
684 Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2021) (1)
Universitet Integrating new approaches to atrial fibrillation management the 6 th AFNET / EHRA Consensus Conference (2018) (1)
How to assess the efficacy of catheter ablation of atrial fibrillation? (2008) (1)
The Impact of Diabetes and Comorbidities on the Outcome of Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Implications for Patient Management. (2016) (1)
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads (2017) (1)
Case Report: Free-Floating Intracoronary Thrombus: Who Is the Convict? (2022) (1)
[Clinical management of older, frail patients with atrial fibrillation. Operative strategies from a multidisciplinary expert group]. (2021) (1)
Mechanisms of atrial fibrillation (1993) (1)
Reverse remodeling after cardiac resynchronization therapy diminishes the need for ICD therapy: the InSync ICD Italian Registry. Abstract European Congress of Cardiology 2007 (2007) (1)
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study (2022) (1)
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? (2021) (1)
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex. (2021) (1)
A31-1 Analysis of atrial tachyarrhythmia organization patterns and implications for the efficacy of a DDDRP pacemaker (2003) (1)
Pacing-induced torsades de pointes after the short-long-short sequence in a patient with a biventricular defibrillator: what is the mechanism? (2014) (1)
AGE-DEPENDENCE OF FLECAINIDE PHARMACOKINETICS (1995) (1)
Prediction of Cardiac Resynchronization Therapy ResponseCLINICAL PERSPECTIVE (2010) (1)
New Options for Pharmacological Conversion of Atrial Fibrillation (2001) (1)
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy. (2022) (1)
Cardiac involvement in laminopathies (2007) (1)
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death. (2022) (1)
Vascular Accesses in Cardiac Stimulation and Electrophysiology: An Italian Survey Promoted by AIAC (Italian Association of Arrhythmias and Cardiac Pacing) (2022) (1)
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry (2022) (1)
Infections of Cardiac Implantable Devices: A Comprehensive Guide (2020) (1)
Utilization, Outcomes and Costs of Implantable Cardioverter Defibrillators in Italy: A Population-Based Analysis Using Healthcare Administrative Databases. (2014) (1)
Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study. (2017) (1)
Celebrating 50 years of electrical therapies for the heart (2007) (1)
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients (2023) (1)
Relationship between frailty and all-cause mortality in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme AF general long-term registry (2020) (1)
Le aritmie in età pediatrica (1998) (1)
Which Is the Ideal Drug for Chronic Prophylaxis of Atrial Fibrillation (2004) (1)
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). (2023) (1)
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension. (2021) (1)
The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: insights from an individual patient data meta‐analysis of COMPANION and CARE‐HF (2022) (1)
Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation. (2007) (1)
[Pseudoischemic T waves: a possible electrophysiologic mechanism]. (1990) (1)
114 Upgrade to biventricular pacing device of pacemaker holders for antibradycardia indications: the Insync/Insync ICD italian registries (2005) (1)
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the ESC-EHRA EORP AF general long-term registry. (2022) (1)
[Appropriateness criteria for the management of anticoagulant therapy in complex patients with atrial fibrillation. The opinion of a group of expert Italian cardiologists]. (2018) (1)
Complicated myocardial infarction in a 99-year-old lady in the era of COVID-19 pandemic: from the need to rule out coronavirus infection to emergency percutaneous coronary angioplasty. (2020) (1)
The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study (2022) (1)
Clinical implications of assessing frailty in elderly patients treated with permanent cardiac pacing. (2022) (1)
Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
Oral loading of propafenone: restoring its role before restoring rhythm. (2017) (1)
[Idiopathic atrial fibrillation: clinical and therapeutic problems]. (1991) (1)
P1-72: Reduction of ventricular pacing in patients with AV block and sinus node disease: Insights from Holter analysis of a new pacing mode (2006) (1)
Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry. (2021) (1)
Atrial fibrillation ablation: beyond electro-mechanical matters. (2008) (1)
Prevalence of the sympathetic influence before atrial fibrillation onset in the so-called “vagal paroxysmal atrial fibrillation patients” (1998) (1)
Prevention of Device Infection: Procedural Aspects, Drugs, and Preventive Tools (2020) (1)
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases (2022) (1)
Response: (2009) (0)
P2121 Cardiac resyncronization therapy: what effects on left and right-ventricular ejection fraction during exercise? (2003) (0)
Prophylactic ICD in female versus male post-infarction patients: data from a real-world registry. Poster European Congress of Cardiology 2008 (2008) (0)
P3784Impact of progressively impaired renal function on major adverse outcomes in European patients with atrial fibrillation: a report from the ESC EORP-AF long-term general registry (2019) (0)
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study". (2022) (0)
Infective endocarditis with perivalvular abscess complicated by septic embolization with acute ST-segment elevation myocardial infarction and peripheral ischemia (2021) (0)
[Action of x-ray on RNA in the neoblasts of Polycelis nigra during regeneration]. (1966) (0)
214 A randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from bradycardia and atrial fibrillation and implanted with a DDDRP device (2005) (0)
Short and long-term outcomes after cardiac surgery in Jehovah’s Witnesses patients: a case–control study (2022) (0)
Poster session 3: Primary prevention and ICD (2009) (0)
Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (2016) (0)
559 SACUBITRIL/VALSARTAN IN “REAL WORLD“ HEART FAILURE PATIENTS: FOCUS ON RENAL FUNCTION AND DRUG TITRATION (2022) (0)
Prediction of atrial fibrillation in patients with heart failure (2010) (0)
Giuseppe Boriani Treated With Cardiac Resynchronization Therapy : Implications for Patient Management The Impact of Diabetes and Comorbidities on the Outcome of Heart Failure Patients (2016) (0)
Rhythm control and increased risk of noncardiovascular death in the Atrial Fibrillation Follow-up Investigation of Rhythm Management trial. (2004) (0)
Implantable cardioverter‐defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the ‘real world’? (2022) (0)
Potential of Medical Treatment, Device Therapy, and Conventional Surgery in Patients Referred for Heart Transplantation (2007) (0)
Biventricular implant procedure in cardiac surgical patients : InSync Italian registry. (2006) (0)
20. ICD: Primary Prevention, Utilization & Costs20.5 Lack of Association Between Tachyarrhythmia and Ventricular Pacing (2005) (0)
Prognostic significance of in-hospital atrial fibrillation across the whole spectrum of acute coronary syndromes (2013) (0)
460Edoxaban versus warfarin in atrial fibrillation patients with low, mid and high body weight: analysis of outcomes in the engage AF TIMI 48 trial (2019) (0)
Sensitivity and specificity of the morphology detection algorithm alone or combined with other algorithms for enhanced diagnostics (2001) (0)
NEW APPLICATIONS OF CARDIOPULMONARY EXERCISE TESTING AND TRAINING IN PAEDIATRIC HEART DISEASE (2016) (0)
711 CROSS-SECTIONAL ANALYSIS OF CARDIOVASCULAR CAUSES OF COMMON PRESENTING SYMPTOMS IN PATIENTS WITH ACTIVE CANCER: THE EXPERIENCE FROM A TERTIARY ONCOLOGICAL CENTRE IN MODENA. (2022) (0)
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 (2007) (0)
Single-lead VDD pacing: a literature review on short-term and long-term performance (2023) (0)
New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development (2023) (0)
Abstracts: Cardio resynchronisation therapy - Outcomes (2009) (0)
Clinical pattern and complications of nonvalvular atrial fibrillation in elderly and nonelderly patients (1998) (0)
444 Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression (2021) (0)
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence (2023) (0)
Impact of body mass index on outcomes in European patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term registry (AFGen LT) (2020) (0)
[The unmet needs of sudden cardiac death. The role of the wearable cardioverter defibrillator when the risk is transient or uncertain]. (2020) (0)
Prediction of Life-threatening Ventricular Tachyarrhythmias and Death in Patients with Previous Myocardial Infarction by Left Ventricular Longitudinal Strain Analysis (2009) (0)
Time-Domain Analysis of the ECG P-Wave after External Cardioversion for Persistent Atrial Fibrillation (2009) (0)
Trans-catheter valve implantation and patient outcomes: Focus on the kidney. (2020) (0)
Factors affecting progression to permanent atrial fibrillation in an unselected population of patients with non-permanent form of atrial fibrillation (2020) (0)
Personalizing configuration for atrial fibrillation external electrical cardioversion to improve first shock efficacy (2022) (0)
Reduction of ventricular pacing versus physician prediction of AV block status. (2006) (0)
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life (2020) (0)
INTRAVENOUS ADMINISTRATION OF PROPAFENONE. AUTHOR'S REPLY (1992) (0)
Cancer and atrial fibrillation. Author's reply. (2019) (0)
Progression of Atrial Fibrillation after Cryoablation. (2023) (0)
P3746Temporal patterns of premature atrial contractions predict atrial fibrillation occurrence in bradycardia patients continuously monitored through pacemaker diagnostics (2019) (0)
Sick sinus syndrome and diffuse impairment of the conduction system in a child: Successful pacing with a steroid eluting endocardial pacing lead (1992) (0)
Risk Stratification in Atrial Fibrillation and Congestive Heart Failure (2003) (0)
Features of Clinical Complexity in European Patients with Atrial Fibrillation: A Report from a European Observational Prospective AF Registry. (2023) (0)
702 Objective daily measurements of patient activity confirm the role of cardiac resynchronization therapy in improving functional status of patients with advanced heart failure (2003) (0)
Cardiac Resynchronization Therapy: State of the Art (2017) (0)
Atrial fibrillation induced by head-up tilt test: prevalence and patients profile (1996) (0)
Management of patients with atrial fibrillation: different therapeutic options and role of electrophysiology-guided approaches. (2001) (0)
Resynchronization Therapy: The InSync ICD (Implantable Antiarrhythmic Effect of Reverse Ventricular Remodeling Induced by Cardiac (2011) (0)
[Clinical practice for the diagnosis of cardiac arrhythmias in patients on renal replacement therapy: data from a Lombard survey]. (2017) (0)
P3446Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry (2018) (0)
Atrial fibrillation: it is better to be alone than in bad company! (2012) (0)
P5781Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish Pacemaker and ICD Registry (2018) (0)
Efficacy and safety of different drug protocols for treating recent - onset atrial fibrillation (1998) (0)
515 Clinical performance of a new atrial automatic threshold testing algorithm (2005) (0)
PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY (2016) (0)
Device Therapy for Atrial Arrhythmias: Latest Topics from the AT500 Italian Registry (2003) (0)
P.1.a.007 A genetic assessment of antipsychotic and antidepressant cardiac iatrogenicity: focus on the proarrhythmic profile (2008) (0)
Persistent atrial fibrillation worsen heart rate variabilità, activity and heart rate, as shown by a continuous minitoring by implantable biventricular pacemakers in heart failure patients. Poster Heart Rhythm 2007, 28th Annual Scientific Session of the Heart Rhythm Society (2007) (0)
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. (2010) (0)
Infection of Cardiac Implantable Electrical Devices: An Emerging Epidemiological Issue (2020) (0)
P6384High proportion of ischemic strokes may be due to low adherence to oral anticoagulation guidelines among patients with atrial fibrillation and stroke risk factors (2018) (0)
Loss of biventricular pacing, inappropriate ICD shocks and uncontrolled ventricular rate associated to atrial fibrillation in patients with cardiac resynchronization therapy defibrillators (2013) (0)
P345 Ventricular fibrillation induction at cardioverter-defibrillator implantation: a controlled comparison between direct current and shock on T (2003) (0)
629 RELATIONSHIP BETWEEN RIGHT/LEFT ATRIAL ECHOCARDIOGRAPHIC PARAMETERS (INCLUDING ATRIAL SPHERICITY) AND OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION (2022) (0)
5045The effect of adaptive cardiac resynchronization therapy in reducing atrial fibrillation in heart failure patients: insights from multicenter observational experience (2018) (0)
P6588Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study (2018) (0)
Cardiac resynchronization therapy: Update on clinical studies (2004) (0)
[Appropriateness criteria for the treatment of atrial fibrillation with dronedarone: practical issues. An Italian cardiologists' expert opinion]. (2013) (0)
Prevention of long-lasting atrial fibrillation through antitachycardia pacing in 584 dual-chamber pacemaker patients (2020) (0)
707 Long-term reduction of atrial fibrillation recurrences in patients paced for bradycardia-tachycardia syndrome (2005) (0)
Poster Session 2: Primary prevention (2009) (0)
Rhythm discrimination in dual-chamber ICDs: differential diagnostic contribution of Morphology Discrimination algorithm in slow versus fast ventricular tachycardia zones (2007) (0)
Atrial Fibrillation Complicated by Heart Failure: First the Chicken or First the Egg? (2002) (0)
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices. (2023) (0)
478 VENTRICULAR AND ATRIAL REMODELING AFTER EDGE-TO-EDGE TRANS-CATHETER MITRAL VALVE REPAIR: A PILOT STUDY (2022) (0)
Role of cardiac imaging in patients undergoing catheter ablation of ventricular tachycardia (2020) (0)
Long-term changes in left atrial function in responders and non-responders to cardiac resynchronization therapy (2013) (0)
GENDERED SOCIAL DETERMINANTS OF HEALTH AND RISK OF MAJOR ADVERSE OUTCOMES IN ATRIAL FIBRILLATION (2023) (0)
[Implantable defibrillators and prevention of sudden death: clinical and economic implications in the light of the MADIT II study]. (2002) (0)
The Daphne study: A randomized trial to test the combined role of drugs and a dedicated device to prevent and treat atrial arrhythmias (2005) (0)
Standard methods fora atrial fibrillation detection compared to continuous monitoring. Poster European Congress of Cardiology 2008 (2008) (0)
P6647Ventricular pacing percentage and atrial fibrillation risk in dual chamber cardiac implantable devices (2018) (0)
O-4 The Italian Network for Laminopathies (2011) (0)
Beat-to-beat variability of P-wave in patients suffering from atrial fibrillation. (2016) (0)
A semi-automatic algorithm for reducing the time spent on routine follow-up of cardioverter defibrillators (2001) (0)
A single-center experience in transvenous coronary sinus lead extraction and re-implantation. Technical issues and alternative re-implantation approaches (2013) (0)
[The CONVERT trial]. (2009) (0)
ICD cost is related to device longevity. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
Cardiac n Therapy: An Overview on Guidelines (2015) (0)
[Role of electrophysiologic study in the sick sinus syndrome and in carotid sinus syndrome]. (1988) (0)
Response: (2011) (0)
Abstract 1891: Mortality After CRT: a Synergetic Effect Between Ventricular Remodeling and Reduced Frequency of Ventricular Arrhythmias. The InSync ICD Italian Registry (2007) (0)
Study on the minimal effective concentration of antiarrhythmic agents. Experience with propafenone (1990) (0)
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study (2022) (0)
[Idiopathic atrial fibrillation: clinical-instrumental characterization and thromboembolic risk]. (1995) (0)
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke. (2022) (0)
P6556Prevention of long-lasting atrial fibrillation through device therapy in dual-chamber pacemakers: analysis on 1384 patients of the role of Reactive ATP and atrial preventive pacing (2019) (0)
Immediate Improvemement of Subepicardial Left Ventricular Twist Predicts Clinical and Echocardiographic Response to Cardiac Resynchronization Therapy (2009) (0)
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome (2022) (0)
Antiarrhythmic Drug Administration before Electrical Cardioversion of Atrial Fibrillation: Is It Useful to Prevent Early Arrhythmia Recurrence? (1998) (0)
P3759Comparison of equations for renal function assessment and major adverse outcomes in atrial fibrillation: an analysis from the EORP-AF long-term general registry (2019) (0)
Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant (2021) (0)
Cost-Effectiveness and Aspects of Health Economics in Primary Prevention: What Is the Case of Dilated Cardiomyopathy? (2006) (0)
P870Occurrence of atrial fibrillation in pacemaker patients and its association with sleep apnea and heart rate variability (2018) (0)
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study (2023) (0)
Effects of Propafenone Plus Digoxin on Ventricular Rate During Atrial Fibrillation: A Randomized Study (1995) (0)
[Refractory sustained ventricular tachycardia. Electrocardiographic characterization and prognosis]. (1988) (0)
Electrical Cardioversion of Atrial Fibrillation or Flutter: Long Term Results. (2004) (0)
Left atrial isolation combined with mitral valve surgery: Hemodynamic evaluation during cardiopulmonary exercise test (1996) (0)
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. (2008) (0)
B-PO03-115 ANTIARRHYTHMIC MEDICATION FOR ATRIAL FIBRILLATION (AIM-AF) STUDY: A PHYSICIAN SURVEY OF ABLATION AND ANTIARRHYTHMIC DRUG USE IN THE USA AND EUROPE (2021) (0)
Performance-based risk-sharing arrangements for devices and procedures in cardiac electrophysiology: an innovative perspective. (2022) (0)
5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry (2017) (0)
[Electrocardiographic, clinical and prognostic evaluation of sustained ventricular tachycardia in acute and chronic ischemic heart disease]. (1989) (0)
Electrophysiology transvenous internal cardioversion for atrial fibrillation: A randomized comparison between catheters with different Coll length (2002) (0)
P515Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (2017) (0)
Long term follow up of patients with sincope evaluated by head up til test. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
M34 ECG Alterations Associated with Psychotropic Drug Use In Clinical Settings: Clinical And Genetic Predictors (2017) (0)
2246Incidence of atrial tachyarrhythmias in patients with pacemakers. A real-world observational research (2017) (0)
1043 INTEGRATED DIAGNOSIS AND TREATMENT IN EOSINOPHILIC MYOCARDITIS, THE IMPORTANCE OF TEAM AGAINST RARE CONDITIONS (2022) (0)
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study (2022) (0)
In Memoriam Luigi Padeletti: an Italian Scientist, an Italian Maestro, an Italian Friend (2018) (0)
[Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up]. (1995) (0)
Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients. (2023) (0)
Results from the RELEVANT study: shockless programming is safe and effective in patients with non ischemic heart failure. Presentation European Congress of Cardiology 2008 (2008) (0)
P3207 Analysis of atrial tachyarrhythmia organization patterns and implications for the efficacy of a DDDRP pacemaker (2003) (0)
1355Real-world observational data confirm the efficacy of atrial antitachycardia pacing in terminating slow and regular atrial tachyarrhythmias in patients wearing implantable cardiac electronic devices (2018) (0)
A28-5 Assessment of rhythm discrimination by QRS morphology analysis in single and dual chamber cardioverter defibrillators (2003) (0)
Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial (2018) (0)
Tracking pacemaker and implantable cardioverter defibrillator utilization rates in Europe 2008–2012Helen Banks (2015) (0)
[Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region]. (2022) (0)
MT1 Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Three European Countries (2020) (0)
Health economy (2018) (0)
88 Trial‐generated patient profiles for implant with electrical devices in chronic heart failure: real‐world prevalence, outcomes and public health implications (2006) (0)
[Hyperkinetic ventricular arrhythmias in acute myocardial infarction: different etiopathogenetic mechanisms?]. (1987) (0)
Clinical usefulness of the left ventricular capture management (LVCM) algorithm. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
Combination of an implantable defibrillator multi-sensor heart failure index and an apnea index for the prediction of atrial high-rate events. (2023) (0)
Prognostic value of renal failure in patients undergoing transvenous lead extraction: single centre experience and systematic review of the literature (2022) (0)
Ten-year follow-up of cardiac resynchronization therapy patients with non-ischemic dilated cardiomyopathy assessed by radionuclide angiography: a single-center cohort study (2022) (0)
[Radiologic study of gallbladder neoplasms: considerations in two cases]. (1949) (0)
963 PRELIMINARY OBSERVANIONAL STUDY ON CARDIAC REMODELING IN PATIENTS UNDERGOING EDGE-TO-EDGE TRANS-CATHETER MITRAL VALVE REPAIR WITH MITRA CLIP DEVICE (2022) (0)
P-052 the daphne study (drug and pace health clinical evaluation): Rationale, design and end-points (2003) (0)
P6074Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry (2018) (0)
Response to resynchronization therapy accordino to the degree of functional impairment at cardiopulmonary exercise testing. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 (2008) (0)
Ventricular fibrillation during sleep in an adolescent with hypertrophic cardiomyopathy: the difficulty of risk stratification and the power of the cardioverter-defibrillator. (2004) (0)
Atrial Fibrillation and Heart Failure: Epidemiologic and Clinical Connections (2003) (0)
Anthropometric parameters and radiation doses during percutaneous coronary procedures. (2022) (0)
Terapia farmacologica in acuto (2009) (0)
Response to resynchronization therapy accordino to the degree of functional impairment at cardiopulmonary exercise testing. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
Optimization of VV delay in devices for cardiac resynchronization therapy: a prospective randomized study. Poster European Congress of Cardiology 2008 (2008) (0)
ICD-detected respiratory disturbance index: accuracy for sleep apnea detection and prognostic value (2020) (0)
P-132 Atrial tachyarrhythmia detection accuracy in DDD pacemakers implanted for brady-tachy form of sick sinus syndrome (2003) (0)
Electrophysiological inducibility does not predict ventricular arrhythmia occurrence in post MI cardiomyopathy. Proceedings XIII International symposium on Progress in Clinical Pacing (2008) (0)
P287015 year trend in ICD utilization according to the Italian national administrative database: an analysis of age groups (2019) (0)
Temporal changes in quality of life amongst European atrial fibrillation patients: relationship to all-cause mortality. A report from the ESC-EHRA EORP-AF General Long-Term Registry (2020) (0)
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
Run baby run … but not too fast! Rate control management in atrial fibrillation: a claim for personalization. (2023) (0)
EFFECTS OF X RADIATION ON THE RNA OF NEOBLASTS OF POLYCELIS NIGRA DURING REGENERATION (1966) (0)
[Use of direct oral anticoagulants in patients with atrial fibrillation and obesity or low body weight: the additional contribution to knowledge provided by pharmacokinetic and pharmacodynamic studies]. (2022) (0)
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. (2004) (0)
Troponin I levels and pacemaker implantation: what clinical implications? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
209 A COMMON CASE OF AORTIC STENOSIS IN A UNIQUE QUADRICUSPID ANATOMY: MANAGEMENT IN REAL LIFE (2022) (0)
424 Differences in ventricular arrhythmias between heart failure patients implanted with biventricular ICD for primary or secondary prevention of sudden death: results of the InSync ICD Italian registry (2003) (0)
22. Miscellanea22.4 Clinical Outcome of a New Automatic Atrial Threshold Testing Algorithm (2005) (0)
OP-EJEC170144 654..659 (2018) (0)
Publisher’s note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (2022) (0)
[Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test]. (1988) (0)
Cardiac resynchronization therapy in very old patients: The insync/insync ICD Italian registries (2005) (0)
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices (2023) (0)
Abstract 20670: Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation (2017) (0)
Analysis and processing of cardiac electrograms in atrial fibrillation. Preface (2001) (0)
P6231Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry (2018) (0)
Cardiac Resynchronization Therapy: The Low Voltage Road or the High Voltage Road? (2004) (0)
P.1.g.046 ECG alterations associated with psychotropic drug use in clinical settings: clinical and genetic predictors (2016) (0)
3293Healthcare resources utilization due to complications of cardiac implantable electronic devices: preliminary results from the IMPACT registry (2018) (0)
In memory of Francesco Furlanello: a great advocate for dedicated commitment to effective, up-to-date, and expert management of cardiac arrhythmias and sports cardiology. (2023) (0)
274Is Adaptive Cardiac Resynchronization Therapy impactful in patient activity? Insights from multicenter observational project (2018) (0)
[Hypertransparent renal calculosis]. (1952) (0)
Abstract 13906: Women and ICD: The Influence of Age and Clinical Characteristics on Survival; the Experience of the Italian ClinicalService Multicenter Observational Project (2015) (0)
P1285Detection of new onset of atrial fibrillation in patients wearing a single chamber defibrillator: insights from a multicentric experience (2018) (0)
612 EVOLUTION OF ATRIAL FIBRILLATION PATTERNS AND IMPACT ON ALL-CAUSE MORTALITY IN A CONTEMPORARY COHORT OF EUROPEAN PATIENTS WITH ATRIAL FIBRILLATION (2022) (0)
Increasing age as a major determinant of major adverse outcomes in patients with atrial fibrillation: the EURObservational research programme in atrial fibrillation general long-term registry (2020) (0)
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS (2020) (0)
Heart failure and trial generated patients' profile for implant with electrical devices: real-world prevalence, outcomes and public health implications. (2006) (0)
P1446Can we predict new atrial fibrillation occurrence in single-chamber ICD patients ? (2017) (0)
Identifying the patient who FADES away prior to appropriate ICD intervention (2012) (0)
Pattern and temporal occurrence of spontaneous atrial and ventricular tachyarrhythmias in patients with a history of atrial tachycardia after ICD implantation (2004) (0)
Patients with previous sincope evaluated with head up til test : long term follow up. Poster European Congress of Cardiology 2008 (2008) (0)
Abstract 10986: Use of the “Pill in the Pocket” Approach for Atrial Fibrillation Termination as Determined from the Antiarrhythmic Medication for Atrial Fibrillation (AIM-AF) Study: A Physician Survey on the Prescription of Antiarrhythmic Drugs in the USA and Europe (2021) (0)
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
328 IMPACT OF INTEGRATED CARE WITH ABC PATHWAY IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE: DATA FROM MORE THAN 11000 PATIENTS ENROLLED IN A EUROPEAN REGISTRY (2022) (0)
Lone paroxysmal atrial fibrillation episodes: Mechanisms of onset and patterns of atrial activation (1990) (0)
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden (2012) (0)
Letter to the Editor Fluttering waves in electrocardiograms recorded in neonatal intensive care unit (2003) (0)
A10-2 Differences in ventricular arrhythmias developed by ischemic and non-ischemic heart failure patients implanted with biventricular cardioverter-defibrillators: The insync icd italian registry (2003) (0)
Use of atrial evoked response response morphology for automatic threshold measurement. (2008) (0)
A giant right coronary artero-venous fistula revealed by an integrated multimodality imaging approach (2020) (0)
Beta-blockers in heart failure patients with atrial fibrillation: Insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (2016) (0)
Tachycardia-related cardiomyopathy: a review of the literature (2013) (0)
The Daphne study: a randomised trial to test the combined role of drugs and dedicated device to prevent and treat atrial tachyarrhythmias (2005) (0)
Regular VV delay optimization is necessary to maintain optimal hemodynamics in CRT-D patients (2006) (0)
P4255Physical activity measured by cardiac implanted devices predicts atrial fibrillation and patient outcomes (2017) (0)
Long-term follow-up of cardiac resynchronization therapy patients with non-ischemic dilated cardiomyopathy assessed by radionuclide angiography (2020) (0)
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target. (2022) (0)
P5656Heart failure clinical phenotypes and outcomes in patients with atrial fibrillation: an analysis from the eurobservational research programme in atrial fibrillation long-term general registry (2019) (0)
136-66: Cardiac resynchronization therapy: a comparison among left ventricular bipolar leads, quadripolar leads and active fixation leads (2016) (0)
Which Resolution for Reliable ECG P-wave Analysis in Atrial Fibrillation? (2011) (0)
P1561Left ventricular reverse remodeling by cardiac resynchronization is associated with lower risk of ventricular tachyarrhythmias (2017) (0)
Longevity of ICDs: are they all comparable? Abstract XIII World Congress on Cardiac Pacing and Electrophysiology (2007) (0)
Introduction (2018) (0)
136-61: Left ventricular Attain Performa quadripolar leads: performance and clinical comparison with left ventricular bipolar leads in cardiac resynchronization therapy. Results from the multicenter JUMP Performa analysis (2016) (0)
Abstract 522: Predictors of Death and Life-threatening Ventricular Tachyarrhythmias in Patients With Previous Myocardial Infarction by Left Ventricular Longitudinal Strain Analysis (2009) (0)
XV CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Naples, Italy - May 20-23, 2015 - Program (Summary) (2015) (0)
‘Pill-in-the-pocket’ treatment for recent-onset atrial fibrillation (2010) (0)
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions. (2022) (0)
Atrial Fibrillation and Heart Failure: Does One Epidemic Feed the Other? (2006) (0)
Letter responding to Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE)-Authors' re (2018) (0)
Impact of physical activity on all-cause mortality in European patients with atrial fibrillation: a report from the ESC-EHRA EORP AF General Long-Term Registry (2020) (0)
Economics of new therapies in electrophysiology (2018) (0)
P1517Risk of acute kidney injury in transcatheter aortic valve implantation procedures and impact on 30-day outcome (2019) (0)
[Hyperkinetic ventricular arrhythmia during the treadmill test in chronic ischemic heart disease]. (1990) (0)
Antiarrhythmic Agents in Atrial Fibrillation: A New Role in the Context of a Hybrid Approach? (2003) (0)
Estimate and reporting of longevity for cardiac implantable electronic devices: a proposal for standardized criteria (2021) (0)
Abstract 17953: Atrial Antitachycardia Pacing and Managed Ventricular Pacing Reduce Long-Lasting AF and AF Burden Compared to Conventional Dual-Chamber Pacing In Bradycardia Patients: Analysis of Minerva Randomized Trial Secondary Endpoints (2013) (0)
868 Best Posters in genetics in hypertension / Best Posters in home and remote monitoring (0)
A plateau waveform shape allows a much higher patient shock energy tolerance (2006) (0)
Response [Pacing and Clinical Electrophysiology] (2009) (0)
P873Detection of new onset of atrial fibrillation in patients wearing a single chamber defibrillator: insights from a multicentric experience (2018) (0)
MADIT II Like Patients in Clinical Practice: The European Prospective Registry (2005) (0)
[Position paper of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) on driving by patients with cardiac implantable electronic devices]. (2020) (0)
Pacemaker-detected severe sleep apnoea predicts new-onset atrial fibrillation: Author's reply. (2018) (0)
Atrial fibrillation in pneumonia: what clinical implications at long-term? (2022) (0)
531The effect of Adaptive Cardiac Resynchronization Therapy in reducing atrial fibrillation in heart failure patients: insights from multicenter observational experience (2018) (0)
COVID-19 pandemic: the potential effects of quarantine-induced stress on arrhythmias (2020) (0)
Evaluation of trial-based eligibility for device therapy in the real world: extent of the overlap between trial generated profiles and associated patients outcomes at 1 year. Poster European Congress of Cardiology 2007 (2007) (0)
The Real Economic Impact of the MADIT-II Study on the European Medical Community (2004) (0)
P948 QT and QTc dispersion increase after successful internal cardioversion of chronic persistent atrial fibrillation: clinical implications (2003) (0)
The pharmacologic approach to patients at risk of sudden cardiac death: not only antiarrhythmic drugs (2007) (0)
823 Cardiac resynchronisation therapy in very old patients (2005) (0)
Time dependency of neuro-hormonal variations after cardiac resynchronisation therapy in heart failure patients (2004) (0)
Poster Session 2: Sudden death and ICD: technical aspects (2009) (0)
Poster session 2 (2011) (0)
P5479Cardiac resynchronization therapy reduces electrical storm incidence over a 3-year follow-up (2017) (0)
3753 Differences in ventricular arrhythmias developed by ischaemic and non-ischaemic heart failure patients implanted with biventricular cardioverter-defibrillators: inSync Italian registry (2003) (0)
Against all odds: Targeted pacing site for resynchronization therapy by venoplasty and active fixation lead. (2015) (0)
ICD longevity: a comparison among manufacturers. Proceedings XIII International symposium on Progress in Clinical Pacing (2008) (0)
Response to the letter from dr bertini. (2013) (0)
Clinical performance of a new atrial automatic threshold testing algorithm (2005) (0)
P-103 Ventricular fibrillation induction at cardioverter-defibrillator implantation: A controlled comparison between direct current and Shock on T (2003) (0)
Clinical performance of a new atrial automatic threshold algorithm (2005) (0)
P325Validation of time-to-battery depletion (remaining longevity) algorithms in modern cardiac resynchronization therapy defibrillators (CRT-Ds) (2018) (0)
Cost-Effectiveness of ICD Implantation in Clinical Settings Different From Ischemic Heart Disease: What Do We Know? (2004) (0)
Lone Atrial Fibrillation: Which Anatomical and Electrophysiologic Substrate? (1996) (0)
[2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up]. (2022) (0)
Timing of cardiac resynchronization therapy implantation. (2023) (0)
Discussion: Contemporary guidelines on implantable cardioverter defibrillator (ICD) therapy do not specifically address recommendations for secondary prevention after life-threatening ventricular arrhythmias due to vasospasm. The arrhythmic risk of coronary vasospasm (2020) (0)
80Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry (2017) (0)
P682Radiotherapy-induced malfunction in cancer patients with cardiac implantable electronic devices (2019) (0)
P5465In CRT-D patients reverse remodeling and occurrence of VT/VF episodes, but not defibrillator therapies, are determinants of death or HF hospitalization risk (2017) (0)
Industry Pulse (2007) (0)
[Paroxysmal atrial fibrillation: the significance of the dynamic behavior of the atrial cycle]. (1993) (0)
Preventing atrial fibrillation in hypertensive patients: the clinical relevance of evidence-based treatment with losartan (2007) (0)
P2781 Haemodynamic improvement following biventricular pacing: is it an on-off phenomenon? (2003) (0)
Lack of association between ventricular pacing and ventricular tachyarrhythmias episodes prompting ICD intervention in a MADIT II-like population: the SEARCH-MI registry preliminary results (2005) (0)
P1532Enhanced longevity of medtronic cardiac resynchronization therapy defibrillators (CRT-Ds): Clinical implications and economic evaluation across european healthcare settings (2017) (0)
Flecainide: Evidence of different concentration-response relationships for antiarrhythmic and electrocardiographic effects (1993) (0)
Short-term hemodynamic effects of sinus rhythm restoration by internal cardioversion in chronic atrial fibrillation (2001) (0)
Oral cardioversion with flecainide in supraventricular arrhythmias (1993) (0)
Smartphone-based cardiac implantable electronic device remote monitoring: improved compliance and connectivity (2022) (0)
P2-87: High incidence of ventricular tachycardia in a pacemaker patient population (2006) (0)
Plasma catecholamines levels during low energy internal cardioversion for persistent atrial fibrillation and during electrophysiological study for ventricular tachyarrhythmias (2001) (0)
Pacemaker syndrome (2018) (0)
695The impact of atrial antitachycardia pacing in terminating slow and regular atrial tachyarrhythmias: data from multicenter experience (2018) (0)
The impact of quality of life scores in patients implanted with defibrillatoors for primary prevention of sudden cardiac death. Proceedings XIII International symposium on Progress in Clinical Pacing (2008) (0)
20. ICD: Primary Prevention, Utilization & Costs (2005) (0)
P6455Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular presentation (2019) (0)
Device therapy: A subcutaneous ICD—preliminary results (2010) (0)
P960 P-wave dispersion: can it differentiate atrial fibrillation patients with and without recurrences after electrical cardioversion? (2003) (0)
Malignant neurocardiogenic syncope: Efficacy and safety of β-blocking treatment guided by head up tilt test (1996) (0)
Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor? (2021) (0)
Role of Peri-infarct Zone Detected With Two-Dimensional Speckle Tracking Echocardiography on Ventricular Arrhythmia Inducibility in Patients With Chronic Ischemic Cardiomyopathy (2009) (0)
Self-reported physical activity and major adverse events in patients with atrial ﬁbrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry , on behalf of the EORP-AF General Pilot Registry Investigators † (2016) (0)
Role of the Automatic Implantable Cardioverter Defibrillator in the Prevention of Sudden Cardiac Death (1992) (0)
A Controlled Comparison BetweenOralLoading DoseandIntravenous Administration (2017) (0)
205 Ventricular arrhythmias of ischemic and non-ischemic heart failure patients implanted with biventricular cardioverter-defibrillators for primary or secondary prevention: InSync ICD Italian registry (2004) (0)
Wednesday, 29 August 2012 (2012) (0)
Rhythm discrimination by analysis of QRS morphology in biventricular cardioverter defibrillators. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
May we improve risk stratification for thromboembolic events by combining CHADS2 score with atrial fibrillation presence and duration? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
Diabetes as a comorbidity of atrial fibrillation in brady tachy syndrome: what impact on arrhythmia occurrence and outcome? (2013) (0)
Ventricular dyssynchrony at rest and during exercise assessed by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques (2008) (0)
Pacing, ICD, or Both for the Hybrid Therapy of Atrial Arrhythmias? (2003) (0)
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing (2004) (0)
P3883Overall and cardiovascular-related mortality after complications of cardiac implantable electronic devices: preliminary results from the IMPACT registry (2018) (0)
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs (2015) (0)
[Not Available]. (1947) (0)
OP-EUPA190261online 515..549 (2020) (0)
[2020 Catheter Ablation Registry of the Italian Association of Arrhythmology and Cardiac Pacing]. (2023) (0)
Cardiac arrest: The need for integrated multi-disciplinary actions for a continuum of care both in acute and at long-term. (2020) (0)
[Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice]. (2012) (0)
P3475Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry (2018) (0)
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies. (2022) (0)
Ventricular pacing has no immediate effect on the occurrence of atrial arrhythmias. Abstract Heart Rhythm 2007, 28th Annual Scientific Session of the Heart Rhythm Society (2007) (0)
704 Electrical storms in patients with biventricular ICD may suggest cardiac resynchronization therapy inefficacy (2008) (0)
[Atrial high-rate episodes: clinical significance, prognostic impact and clinical management]. (2020) (0)
P381 Rhythm discrimination by QRS morphology analysis: what performance in presence of a wide QRS complex? (2003) (0)
[Non-invasive diagnosis of acute rejection in heart transplant]. (1989) (0)
Vitamin D Low-Levels and Silent Myocardial Ischemia in Type 2 Diabetes: Clinical Correlations and Prognostic Significance (2020) (0)
Poster session 3: Pacemaker and sensor algorithm (2009) (0)
43 – Establishing and Managing a Device Clinic and Database (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giuseppe Boriani?

Giuseppe Boriani is affiliated with the following schools:

University of Modena and Reggio Emilia
Marche Polytechnic University
University of Bologna
Leiden University

Giuseppe Boriani's Academic­Influence.com Rankings

Why Is Giuseppe Boriani Influential?

Giuseppe Boriani's Published Works

Published Works

What Schools Are Affiliated With Giuseppe Boriani?

Giuseppe Boriani's AcademicInfluence.com Rankings